A First-in-human Phase 1 Study of CP1050

Clinical trial NCT03468413 · UNKNOWN

Trial details

NCT number: NCT03468413
Sponsor: Curadim Pharma Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2018-02-05
Primary completion: 2018-08-01
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.